Skip to Main Content

Paper Details

Identification of a Molecularly-Defined Subset of Breast and Ovarian Cancer Models that Respond to WEE1 or ATR Inhibition, Overcoming PARP Inhibitor Resistance.
Clin Cancer Res
15
2022
Author NameAffiliation
Zhongwu LaiAstraZeneca Oncology R&D
Joshua ArmeniaAstraZeneca Oncology R&D
Alejandra BrunaCambridge Institute
Carlos CaldasCambridge Institute
Gordon B MillsKnight Cancer Institute, Oregon Health and Sciences University
Gordon B MillsThe University of Texas MD Anderson Cancer Center
Gordon B MillsKnight Cancer Institute, Oregon Health and Sciences University
Gordon B MillsThe University of Texas MD Anderson Cancer Center
J. Carl BarrettAstraZeneca Oncology R&D
  • 1 - 9

Datasets

Release 1.2